Why the study?
Does elective stenting provide safe and effective immediate and long-term results in patients with unprotected left main coronary artery disease?
Does elective stenting provide safe and effective immediate and long-term results in patients with unprotected left main coronary artery disease?
Elective stenting for unprotected left main coronary artery disease is feasible with high acute procedural success, though symptomatic recurrence occurs in 20% of patients at 16 months.
Answers are grounded in this paper and cite their sources.
Supports feasibility of elective stenting for unprotected left main disease; leaves open durability versus alternatives in randomized trials.
The standard treatment of left main coronary artery (LMCA) disease has been bypass surgery (CABG). Recent reports suggested that stenting of LMCA disease might be feasible. From January 1995 to April 1998, we carried out a prospective study of elective stenting of unprotected LMCA disease to evaluate its immediate and long-term results. Of 61 consecutive patients with unprotected LMCA disease, 6 were excluded. Acute procedural success was 100% for the remaining 55 patients, without any complications such as stent thrombosis, myocardial infarction, CABG, or death. During a mean follow-up of 16.1+/-9.6 months, 11 patients (20%) had symptomatic recurrence, between 2 to 6 months after their procedure. Seven patients underwent CABG, two had repeat intervention, one continued with medical therapy, and one died before planned angiography. There was no late sudden death. Forty-four patients (80%) remained asymptomatic. We conclude that elective stenting may be a safe alternative to CABG in unprotected LMCA disease.
No takes yet. Share an insight, caveat, or question.
Wong et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: